Raymond James cuts Axon stock price target on federal delays

Axon reported Q3 revenue of $909 million, up 28% year over year but about $28 million below Street estimates; adjusted EBITDA of $236 million beat Street forecasts by about $8 million. Three delayed federal Dedrone projects, representing approximately $130 million of anticipated second-half 2026 revenue, prompted lower guidance and contributed to hardware and margin concerns. Raymond James cut its price target to $475 from $675 while retaining an Outperform rating; software and Services revenue grew 43%, and ARR rose 40% to $1.75 billion.

Analysis

The key issue is not whether demand for Axon’s software is intact; it is whether investors will continue to value that recurring growth as a stabilizer while hardware and federal-program timing make reported growth and margins less predictable. Strong software retention can support the long-term case, but it does not eliminate near-term estimate risk: procurement slippage can shift revenue across quarters, while counter-UAS mix and memory costs can dilute the benefit of software scale. A further cut to the valuation multiple is possible if investors begin treating these delays as evidence of structurally less-convertible bookings rather than timing noise.

Over the next 1–3 months, federal procurement updates, bookings, and management’s ability to preserve its software outlook matter more than the delayed revenue amount in isolation. Over 6–18 months, the test is whether software growth and recurring revenue offset hardware volatility without requiring margin concessions. The Skydio investment adds strategic exposure to autonomous systems, but the public-market repricing of drone companies raises the opportunity cost of that capital; absent disclosed return milestones, it is not yet a reliable valuation support.

Contrarian angle: the selloff may overstate deterioration if federal projects are genuinely deferred, not canceled, and software metrics remain durable. But calling the shares undervalued on that basis alone is premature without evidence on project conversion, bookings, and gross-margin trajectory. Motorola Solutions may benefit at the margin if customers delay Axon hardware deployments, though there is no basis here to assume direct substitution.

Key Decisions for Investors

• Do not add solely because the shares are near a 52-week low. Keep AXON exposure sized for further estimate and multiple risk until the next reporting update clarifies whether the federal delays converted into scheduled procurement or cancellations.
• Treat AXON as a conditional 1–3 month long, not a confirmed turnaround: add only if bookings/project timing stabilize and software growth remains intact without renewed deterioration in gross-margin guidance. This offers upside participation while avoiding an unsupported price target.
• Watch quarterly bookings, software and services growth, net revenue retention, gross margin, and conversion timing for the delayed federal projects. A further bookings slowdown, software deceleration, or margin pressure despite memory-cost relief would falsify the resilient-software thesis and argue against adding.
• For the 6–18 month view, require clearer Skydio investment milestones—commercial adoption, expected returns, or capital commitments—before assigning strategic value to the investment; absent those disclosures, treat it as capital-allocation risk rather than a catalyst.